Skip to main content
Premium Trial:

Request an Annual Quote

DxTerity Lands $7.5M in Debt Financing

NEW YORK (GenomeWeb) – DxTerity Diagnostics announced on Tuesday that it has arranged to receive up to $7.5 million in term debt financing from SWK Funding, a subsidiary of SWK Holdings.

The firm said it will use the proceeds toward the commercialization of its DxDirect genomics testing platform and DxCollect MicroCollection Device (MCD).

The firm's proprietary chemistry, DxDirect, enables multiplexed genomic testing directly from the patient sample. The DxCollect MCD allows for the stabilization and transport of blood RNA collected from a finger or heel prick.

"This funding allows DxTerity to aggressively pursue the commercialization of its technology, including [the] expansion of DxDirect to next-generation sequencing systems, and [the use of] DxCollect MCD to power direct-to-patient clinical studies for accelerated validation of molecular diagnostic assays," DxTerity CEO Bob Terbrueggen said in a statement.

In February, a partnership between DxTerity and Duke University received $10.4 million from the US Department of Health and Human Services Biomedical Advanced Research and Development Authority to continue developing a genetic test for radiation exposure.

 

 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.